Published in Clin J Pain on December 13, 2002
A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med (2008) 2.60
Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56
Multiple actions of spinophilin regulate mu opioid receptor function. Neuron (2008) 1.30
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc Natl Acad Sci U S A (2006) 1.28
Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J (2004) 1.22
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A (2005) 1.14
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res (2008) 1.12
Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J (2008) 1.11
Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications. Drug Alcohol Depend (2010) 1.11
A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc (2009) 1.10
A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci (2011) 1.09
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol (2011) 1.07
Synaptic mechanism for functional synergism between delta- and mu-opioid receptors. J Neurosci (2010) 1.06
Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence. BMC Neurosci (2010) 1.05
Rapid delivery of internalized signaling receptors to the somatodendritic surface by sequence-specific local insertion. J Neurosci (2010) 1.04
Pain management following spinal surgeries: An appraisal of the available options. J Craniovertebr Junction Spine (2015) 1.02
In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function. Eur J Pharm Sci (2010) 0.95
Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids. Am J Gastroenterol (2015) 0.92
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Eur J Clin Pharmacol (2010) 0.90
Epileptiform synchronization in the cingulate cortex. Epilepsia (2008) 0.88
Transdermal buprenorphine - a critical appraisal of its role in pain management. J Pain Res (2009) 0.88
Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice. Mol Pain (2008) 0.88
A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor. PLoS One (2013) 0.88
Modulation of opioid receptor function by protein-protein interactions. Front Biosci (Landmark Ed) (2009) 0.88
Going beyond efficacy: strategies for cancer pain management. Curr Oncol (2008) 0.88
When it comes to opiates, just say NO. J Clin Invest (2007) 0.86
Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids (2011) 0.86
The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesth Analg (2008) 0.84
R7BP modulates opiate analgesia and tolerance but not withdrawal. Neuropsychopharmacology (2011) 0.84
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. J Am Chem Soc (2016) 0.84
Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement. Proc Natl Acad Sci U S A (2016) 0.83
GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner. J Neurosci (2015) 0.83
Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy. CPT Pharmacometrics Syst Pharmacol (2016) 0.82
RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn. Neurosci Lett (2011) 0.82
Structural basis for μ-opioid receptor binding and activation. Structure (2011) 0.81
The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam Horm (2010) 0.81
Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation. PLoS One (2015) 0.81
Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis. Brain Res (2007) 0.81
Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. Pain Res Manag (2008) 0.80
Acute oxycodone induces the pro-emetic pica response in rats. J Pharmacol Exp Ther (2011) 0.80
Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids. Eur J Pain Suppl (2011) 0.80
Respiratory effects of chronic in utero methadone or morphine exposure in the neonatal guinea pig. Neurotoxicol Teratol (2008) 0.80
Analgesic tolerance to morphine is regulated by PPARγ. Br J Pharmacol (2014) 0.79
Oxycodone combinations for pain relief. Drugs Today (Barc) (2010) 0.79
The pathogenesis and medical treatment of spondylogenic pain. Asian Spine J (2010) 0.79
Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci (2014) 0.79
The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review. Pain Ther (2017) 0.78
Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis. Eur J Pharm Sci (2014) 0.78
Weighing the balance: how analgesics used in chronic pain influence sleep? Br J Pain (2014) 0.77
Excitatory and inhibitory effects of opioid agonists on respiratory motor output produced by isolated brainstems from adult turtles (Trachemys). Respir Physiol Neurobiol (2009) 0.77
In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice. Drug Metab Dispos (2015) 0.77
Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats. Peptides (2012) 0.76
BK channels in microglia are required for morphine-induced hyperalgesia. Nat Commun (2016) 0.76
Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5. Neuroscience (2010) 0.76
Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect Profile. Int J Med Chem (2012) 0.76
Advances in opioid therapy and formulations. Support Care Cancer (2004) 0.76
Fatal intoxication caused by the application of the multiple transdermals patchs of fentanyl. Pan Afr Med J (2015) 0.75
Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors. Br J Pharmacol (2017) 0.75
Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not. Physiol Behav (2009) 0.75
BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice. Br J Pharmacol (2016) 0.75
Single-sweep spectral analysis of contact heat evoked potentials: a novel approach to identify altered cortical processing after morphine treatment. Br J Clin Pharmacol (2015) 0.75
Doctor Shopping Behavior and the Diversion of Prescription Opioids. Subst Abuse (2017) 0.75
Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes. Eur J Pain (2011) 0.75
Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta). J Vet Pharmacol Ther (2014) 0.75
Fentanyl, but not haloperidol, entrains persisting circadian activity episodes when administered at 24- and 31-h intervals. Behav Brain Res (2009) 0.75
Advances in opioid pharmacology. Support Care Cancer (2004) 0.75